Press Release
Dec. 15, 2025
VANCOUVER –
Summary:
As part of Look West’s goal to boost B.C.’s life-sciences and biomanufacturing capabilities and economic potential, the Province is enhancing B.C.’s and Canada’s readiness for future pandemics and ability to develop and manufacture treatments domestically, while creating new jobs.
“B.C. is home to the fastest-growing life-sciences sector in Canada, thanks to our world-class work force and business leaders,” said Ravi Kahlon, Minister of Jobs and Economic Growth. “With unprecedented uncertainty and disregard for science and scientific expertise from our neighbours in the United States, it’s vital that we double down on investing in Canadian research and infrastructure that allow us to develop, test and commercialize life-saving technologies right here in B.C. It’s part of our Look West economic plan to drive growth and deliver innovative solutions at home and around the world.”
The Government of B.C. is providing $33 million for research equipment and facilities for Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH), a national initiative led by the University of British Columbia that aims to establish 100-day, start-to-finish drug development in B.C. for Canada. The investment supports three projects led by UBC researchers, and one led by researchers at Simon Fraser University (SFU).
Building on B.C.’s Life Sciences and Biomanufacturing Strategy, this investment will bring cutting-edge research infrastructure for drug-development capabilities and training to British Columbia, which is critical to creating the next generation of B.C. life-sciences entrepreneurs and companies. The hub is expected to attract and train top talent and provide local businesses with more opportunities to collaborate with academia, expand their operations, innovate and compete on a global scale.
The announcement was made as UBC broke ground on a new building, The Edge, that will house the advanced therapeutics manufacturing facility (ATMF), one of four funded projects. Researchers and biotech start-ups will use the facility to develop, manufacture and commercialize treatments for a range of health conditions, from infectious diseases to cancer and autoimmune disorders.
“The ATMF will provide UBC students like me the unique opportunity to see our research through, from the first findings all the way to clinical-grade manufacturing, ensuring our ideas can grow right here in B.C. and help people in local communities,” said Dana Lao, a master’s student at the UBC faculty of medicine who is developing cell therapies that could improve bone-marrow-transplant outcomes and treat conditions like type-1 diabetes. “This hands-on training in biomanufacturing will prepare us to lead the future of B.C.’s life-sciences sector and to develop cutting-edge therapies for people here at home and across the globe.”
CIEBH is a consortium of more than 50 academic, industry, not-for-profit and health-system partners that aims to accelerate drug development through advanced research, talent development, biomanufacturing for clinical trials, and commercialization of treatments in Canada.
Supporting innovation
The Province’s $33-million investment leverages $140 million from the federal government and more than $22 million from other sources, bringing total funding for CIEBH projects to $195 million.
The provincial investment includes more than $22 million to help build the ATMF, the first of its kind in Western Canada. The 2,300-square-metre facility fills a critical gap in Canada’s ability to develop, test and manufacture life-saving medicines here at home.
The ATMF project is co-led by Megan Levings, professor of surgery and biomedical engineering at UBC, and Robert Holt, professor of molecular biology and biochemistry at SFU, and professor of medical genetics at UBC.
“The ATMF will give researchers and biotech startups the ability to manufacture advanced, clinical-grade therapies right here in B.C., instead of sending promising discoveries out of the province,” Levings said. “That means keeping more Canadian science in Canada, powering up B.C.’s life-sciences sector with discoveries, skilled talent, new companies and jobs, while also accelerating translation from the lab to clinic so patients have access to life-saving treatments.”
Additional CIEBH projects
The remaining provincial funding for CIEBH projects includes:
Each of the projects include skills-training components that will help strengthen B.C.’s life-sciences and biomanufacturing workforce.
“Health care is expected to create nearly 200,000 job openings over the next decade, and this investment helps make sure people in B.C. are ready to fill them,” said Josie Osborne, Minister of Health. “By developing and producing new medicines right here at home, we can get treatments to patients faster, be better prepared for future health emergencies and create good jobs for people in our communities. This is about building a stronger, safer and healthier future for everyone in British Columbia.”
More funding for research projects
Funding for the CIEBH projects is part of the B.C. Knowledge Development Fund (BCKDF), the Province’s primary source for capital investment in research infrastructure.
The Province is also providing an additional $15.3 million to support 71 other research projects at UBC and UBC Okanagan in areas including life sciences, clean tech, natural resources and agrifoods.
This work is part of the Province’s Look West plan for jobs and industry, which outlines B.C.’s vision to deliver jobs and opportunities by strengthening the workforce to develop a more independent economy. This includes delivering major projects quicker, diversifying markets and growing targeted sectors, such as technology, aerospace, marine, AI and quantum, life sciences, agriculture and construction innovation.
Quick Facts:
Learn More:
Two backgrounders follow.
Contacts:
Ministry of Jobs and Economic Growth
Media Relations
250-880-5179
Brett Goldhawk
Faculty of Medicine
University of British Columbia
778-952-7858
Will Henderson
Simon Fraser University
604-368-2532
BACKGROUNDER 1
What people are saying about expanded life-sciences, drug-development funding
Benoit-Antoine Bacon, president and vice-chancellor, UBC –
“This important investment in Canada’s Immuno-Engineering and Biomanufacturing Hub builds on UBC’s global strength in life sciences and ensures that health-research breakthroughs made in B.C. can be developed, manufactured, and delivered to improve lives here and around the world. UBC is grateful to the Government of British Columbia for its partnership and critical support of research and innovation infrastructure. The funded projects, spanning fields from life sciences and clean tech to artificial intelligence and natural resources, will strengthen B.C.’s leadership in discovery and talent development across disciplines.”
Joy Johnson, president and vice-chancellor, Simon Fraser University –
“SFU is proud to contribute to made-in-B.C. innovations and the province’s growing life-sciences sector through Canada’s Immuno-Engineering and Biomanufacturing Hub. We are committed to research for real impact and making a difference for B.C. through collaboration with academia, industry and community partners as we strive to help create healthier, more resilient communities in B.C. and beyond.”
Kelley Lee, professor, Canada Research chair Tier I in Global Health Governance –
“The Bridge Research Consortium is grateful to receive this generous funding to support social innovation that brings together diverse perspectives spanning science, industry, government and communities, including vital work that strengthens public understanding and equitable access to vaccines.”
Wendy Hurlburt, president and CEO, Life Sciences British Columbia –
“This investment strengthens B.C.’s position as a global life-sciences leader and reinforces our capacity to innovate, manufacture and deliver health solutions here at home. The CIEBH is an important investment for our province, supporting health security, driving economic growth and developing a skilled workforce that creates high-value jobs for British Columbians.”
Lesley Cormack, principal and deputy vice-chancellor, UBC Okanagan –
“From projects in critical minerals to affordable housing, health and beyond, these investments in research infrastructure at UBC Okanagan are essential to strengthening innovation in the B.C. Interior and supporting economic growth and diversification in this region of the province. I want to reiterate our gratitude to the government of B.C. for its crucial support and investments through the B.C. Knowledge Development Fund.”
Contacts:
Ministry of Jobs and Economic Growth
Media Relations
250-880-5179
Brett Goldhawk
Faculty of Medicine
University of British Columbia
778-952-7858
Will Henderson
Simon Fraser University
604-368-2532
BACKGROUNDER 2
Additional UBC research projects supported by the B.C. Knowledge Development Fund
Total UBC funding: $13,694,497
Total UBC Okanagan funding: $1,680,370
Contacts:
Ministry of Jobs and Economic Growth
Media Relations
250-880-5179
Brett Goldhawk
Faculty of Medicine
University of British Columbia
778-952-7858
Will Henderson
Simon Fraser University
604-368-2532
IHT5